Mar 12, 2020
Military exercise highlights multi-function capabilities and operational readiness of semiconductor technology
Nov 25, 2019
INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer
Aug 19, 2019
HedgePath Pharmaceuticals Announces Name Change to INHIBITOR Therapeutics, Inc. and Ticker Symbol Change to "INTI" Effective August 20, 2019
May 29, 2019
HedgePath Pharmaceuticals Announces Notice of Allowance with Additional Claims Governing the Use of SUBA®-Itraconazole for the Treatment of Lung Cancer
May 06, 2019
HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Treatment of Prostate Cancer
Apr 17, 2019
Senhwa Biosciences Silmitasertib / Basal Cell Carcinoma Trial Completed 1st Patient Enrollment
Feb 19, 2019
Hedgehog Launches Sitecore as a Service Solution for Lower Midmarket Customers
Dec 17, 2018
HedgePath Pharmaceuticals and Mayne Pharma Enter into Updated Collaboration and Funding Agreements
Nov 28, 2018
Researchers Regrow Hair on Wounded Skin
Oct 11, 2018
HedgePath Pharmaceuticals to Present at the 2018 BioFlorida Annual Conference
Oct 09, 2018
HedgePath Pharmaceuticals' Pathway for Filing SUBA BCCNS NDA Clarified in Meeting with FDA
Aug 06, 2018
HedgePath Pharmaceuticals Announces Positive FDA Feedback from FDA Type-C Meeting and Files Pre-NDA Meeting Request
Jul 19, 2018
HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
Jul 09, 2018
HedgePath Pharmaceuticals Closes Second Tranche of Mayne Pharma Financing
Jun 05, 2018
HedgePath Pharmaceuticals Granted Meeting with FDA to Discuss SUBA BCCNS Trial Data and Regulatory Pathway
May 21, 2018
HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage
May 14, 2018
HedgePath Pharmaceuticals Announces Expanded Patent Coverage
Oct 30, 2017
HedgePath Pharmaceuticals Completes Enrollment for its Phase 2(b) Trial in BCCNS and Provides Trial Update
Oct 09, 2017
HedgePath Pharmaceuticals, Inc. Presentation Now Available for On-Demand Viewing
Sep 28, 2017
HedgePath Pharmaceuticals, Inc. to Webcast, Live, at VirtualInvestorConferences.com October 5